2023-07-24 16:12:02
For the moment, the test is mainly used for pharmaceutical companies in the development of new pills. The test is also used by doctors at the CHC Montlégia in Liège.
In the future, Laure Morimont hopes that the test will be implemented in all the provinces of the country. “The objective is to make general practitioners and gynecologists aware of the usefulness of this test so that they can prescribe it to their patients who wish to start taking the pill and to those who are already on the pill and who would like to know their risk, or even during pregnancy and menopause (for women who wish to take hormone replacement therapy)..
“Currently, the test is payable by the patient or the laboratory for a price of around 50 euros“, specifies the UNamur. “Nevertheless, a partnership is underway with a major player in the in vitro diagnostics sector in order to make the test available on an automated platform and allow its marketing on a European and then worldwide scale.“, she assures.
This would facilitate its use and its implementation in clinical routine, which would ultimately reduce the associated cost or even obtain intervention from health insurance.
1690258989
#risk #developing #thrombosis #birth #control #pill #blood #test #exists #find
